AI Articles and Analysis about Marketing and advertising

The applications of AI in the healthcare and life sciences industries are vast, with data-powered algorithms and analytics promising to upend the status quo. Applications, including the use of AI to interpret medical imaging, optimize drug discovery and development, analyze large-scale data sets to identify patterns among patient populations, and streamline provider workflows, are already transforming the industry. 

Over the last decade, public introductions of advanced technologies from big tech firms, such as Google Glasses and Meta's (then-Facebook) Metaverse platform, were met with infamous disappointment. In stark contrast, initial iterations of generative AI (GenAI) in large language models and other tools deployed across the global economy by smaller players like OpenAI in the last few years are having a far more lasting impact. A recent report from McKinsey noted that the staying power of GenAI could add $2.6 trillion to 4.4 trillion USD annually to the global economy.

As new generative AI use cases continue to reshape the enterprise landscape across the global economy, many sectors are still weathering significant risks to keep pace with the adoption hype. Deloitte's "State of Generative AI in the Enterprise 2024" report found that 79% of respondents expect generative AI to transform their organizations within three years. However, companies must approach these investments cautiously with a focus on responsible implementation. 

Dell Technologies Inc., or simply 'Dell', is a Texas-based multinational technology company. Dell is predominantly known for its personal computing products, particularly its desktops, laptops, and workstations. Gradually, the company branched out into other product and service offerings, including network equipment, software and cloud solutions, and automation services.

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Riskified and was written, edited and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

This interview analysis is sponsored by Uniphore and was written, edited and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.